文献速递消化、代谢与肾脏急症

临床风险评分对急性下消化道出血不良结局及安全出院的预测价值

Predictive value of clinical risk scores for adverse outcomes and safe discharge in acute lower gastrointestinal bleeding.
PubMed 文献 · Am J Emerg Med · 2025-10-25
一句话结论在急性下消化道出血患者中,Oakland评分对不良结局、严重出血和安全出院的预测性能最高(AUC 0.902、0.925、0.889),SALGIB评分次之。

这项回顾性队列研究纳入2017年10月1日至2022年10月1日期间某三级培训与研究医院急诊科收治的2051例成人急性下消化道出血患者,计算CHAMPS、NOBLADS、Oakland、SALGIB和Strate评分并评估其预测价值。792例(38.6%)发生不良结局,611例(29.8%)发生严重出血,752例(36.7%)需要输血,67例(3.3%)接受治疗性干预。Oakland评分对不良结局、严重出血和安全出院的预测性能最高(AUC分别为0.902、0.925、0.889),SALGIB评分次之(AUC分别为0.880、0.901、0.867),其余评分预测性能中等。作者认为Oakland和SALGIB评分可能有助于识别不良结局风险患者并做出安全出院决策。

要点

  • 在2051例急性下消化道出血成人患者中,Oakland评分对不良结局的预测AUC为0.902,对严重出血为0.925,对安全出院为0.889,均为最高。
  • SALGIB评分对不良结局、严重出血和安全出院的AUC分别为0.880、0.901和0.867,预测性能仅次于Oakland评分。
  • CHAMPS、NOBLADS和Strate评分对上述三项结局的预测性能均为中等。
  • 总体不良结局发生率为38.6%(792/2051),严重出血发生率为29.8%(611/2051),输血需求为36.7%(752/2051),治疗性干预为3.3%(67/2051)。
  • 作者认为Oakland和SALGIB评分可能有助于临床医生识别急性下消化道出血患者的不良结局风险并做出安全出院决策。

适用人群与场景

  • 成人(≥18岁)急性下消化道出血患者,最终诊断由急诊科确定。
  • 研究纳入2017年10月1日至2022年10月1日期间某三级培训与研究医院急诊科收治的患者。

研究设计与关键结果

  • 研究类型为回顾性队列研究,纳入2051例成人急性下消化道出血患者,中位年龄59岁(IQR 42-75),女性占40.7%。
  • 不良结局(院内死亡、严重出血、输血需求及治疗性干预)发生于792例(38.6%),严重出血611例(29.8%),输血752例(36.7%),治疗性干预67例(3.3%)。
  • Oakland评分对不良结局的AUC为0.902,对严重出血的AUC为0.925,对安全出院的AUC为0.889。
  • SALGIB评分对不良结局的AUC为0.880,对严重出血的AUC为0.901,对安全出院的AUC为0.867。
  • CHAMPS、NOBLADS和Strate评分对三项结局的预测性能均为中等。

证据类型、等级与局限

  • 证据类型:回顾性队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为Oakland和SALGIB评分可能有助于临床医生识别急性下消化道出血患者的不良结局风险并做出安全出院决策。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: This study aims to evaluate the predictive value of various clinical prediction tools in predicting adverse outcomes and safe discharge in patients with lower gastrointestinal bleeding (LGIB).

METHODS: This retrospective cohort study was conducted in the emergency department of a tertiary training and research hospital between October 1, 2017, and October 1, 2022. Adult patients (≥18 years) with a final diagnosis of acute LGIB were included. Demographics, medication history, chief complaints, vital signs, physical examination findings, laboratory results, bleeding sources, adverse outcomes (in-hospital mortality, severe bleeding, transfusion needs, and therapeutic interventions), and the variables needed to calculate the CHAMPS, NOBLADS, Oakland, SALGIB, and Strate scores were recorded, and analysis was performed.

RESULTS: A total of 2051 patients were included in the final analysis. The median age of the patients was 59 years (IQR: 42-75), and 40.7 % were female. An adverse outcome occurred in 792 (38.6 %) patients, and severe bleeding occurred in 611 patients (29.8 %). A total of 752 patients (36.7 %) required blood transfusions, and 67 patients (3.3 %) underwent therapeutic intervention. The Oakland score demonstrated the highest predictive performance for adverse outcomes (AUC: 0.902), severe bleeding (AUC: 0.925), and safe discharge (AUC: 0.889). The SALGIB score followed, with AUC values of 0.880, 0.901, and 0.867, respectively, for the same outcomes. The remaining scores exhibited moderate predictive performance across all three outcomes.

CONCLUSION: The Oakland and SALGIB scores outperformed other clinical prediction tools and may aid clinicians in identifying patients at risk of adverse outcomes and making safe discharge decisions in acute LGIB.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. İlhan B, Aydın H, Şahin N, et al. Predictive value of clinical risk scores for adverse outcomes and safe discharge in acute lower gastrointestinal bleeding. Am J Emerg Med. 2025. PMID: 41175440. doi:10.1016/j.ajem.2025.10.051

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。